Two Democratic senators allege Tesla used 'misleading and incomplete' Full Self Driving safety statistics, citing a May 2026 Reuters investigation that found the company may have overstated its safety record by claimi... On the same day as the regulatory pressure, Goldman Sachs analyst Mark Delaney raised Tesla's Q2...

Create a landscape editorial hero image for this Studio Global article: What did two Democratic U.S. senators allege about Tesla's Full Self-Driving (FSD) safety data in a June 16 letter to NHTSA, what evidence d. Article summary: ## Senators' Allegations Against Tesla's FSD Safety Data. Topic tags: general, general web, user generated, government, news. Reference image context from search candidates: Reference image 1: visual subject "# Senators call for investigation into Tesla’s ‘Full Self-Driving’ after train crossing incidents. The senators' letter comes after NBC News reviewed dozens of driver complaints al" source context "Senators call for investigation into Tesla’s ‘Full Self-Driving’" Reference image 2: visual subject "# Senators call for investigation into Tesla’s ‘Full Self-Driving’ after train crossing incidents. The senators' letter comes after NBC News reviewed dozens of d
Tesla faced a stark split-screen on June 16, 2026, as renewed regulatory pressure over its Full Self-Driving (FSD) safety claims collided with an upgraded delivery forecast from Goldman Sachs. Two prominent Democratic senators formally accused the company of deploying misleading safety statistics, while Wall Street analysts pointed to stronger-than-expected global sales. The juxtaposition captures the persistent tension between Tesla's autonomous-driving ambitions and the reality of its core automotive business.
In a letter sent to National Highway Traffic Safety Administration (NHTSA) Administrator Jonathan Morrison on June 16, 2026, Senators Edward Markey (D-Mass.) and Richard Blumenthal (D-Conn.) alleged that Tesla has used "misleading and incomplete" statistics to promote its FSD technology . The senators explicitly cited a May 2026 Reuters investigation that concluded Tesla may have overstated the safety performance of its driver-assistance system
.
At the center of the dispute are Tesla's public claims that its FSD-equipped vehicles are up to 10 times safer than human-driven cars and experience 85% fewer accidents . The senators argued these sweeping assertions are not supported by Tesla's own self-reported accident data. The letter demanded that NHTSA "properly and fully investigate" whether Tesla's safety claims constitute deceptive practices and called for greater transparency across the autonomous-vehicle industry
.
This is not the first time Senators Markey and Blumenthal have pressed regulators to examine Tesla's driver-assistance systems. In September 2025, the same pair wrote to NHTSA urging an investigation into FSD failures at railroad crossings, following an NBC News report documenting owners' complaints that the software sometimes failed to detect approaching trains . By October 2025, NHTSA had opened an investigation into that issue
.
By March 2026, the agency escalated its broader FSD probe from a Preliminary Evaluation to an Engineering Analysis, covering an estimated 3.2 million vehicles and focusing on whether the system failed to adequately detect reduced-visibility conditions . The senators' June 2026 letter builds on this accumulating scrutiny, now zeroing in on what they describe as a gap between Tesla's marketing claims and its underlying data.
On the same day the senators' letter made headlines, Goldman Sachs analyst Mark Delaney issued a research note raising the firm's Q2 2026 delivery forecast for Tesla from 405,000 to 420,000 vehicles, surpassing the Visible Alpha consensus estimate of approximately 400,000 .
The upgrade was based on regional sales data showing strong performance across the United States, Europe, China, South Korea, and Australia . Delaney wrote that Tesla's deliveries are "likely tracking ahead of consensus" for the quarter
. Goldman also nudged its full-year 2026 delivery estimate slightly higher, from 1.72 million to 1.73 million vehicles, while maintaining a Neutral rating and a $375 price target on Tesla stock
.
The delivery forecast increase signals confidence in Tesla's near-term operational momentum, even as the company faces a maturing EV market and increasing competition. Goldman's note suggested Tesla is outperforming market expectations heading into the end of the second quarter.
TSLA shares declined following the senators' letter, with one report attributing the drop directly to concerns over "misleading" FSD safety data . The contrasting headlines encapsulate the dual narrative surrounding Tesla: its core vehicle-sales business continues to show strength, but its autonomous-driving ambitions — a major driver of long-term valuation — face mounting regulatory and credibility challenges.
The events of June 16, 2026, illustrate how Tesla's stock increasingly reacts to both its operational delivery numbers and the regulatory trajectory of its FSD program. With NHTSA's engineering analysis already underway and lawmakers intensifying their demands for transparency, Tesla's ability to substantiate its safety claims will be closely watched by investors, regulators, and consumers alike.
Studio Global AI
Use this topic as a starting point for a fresh source-backed answer, then compare citations before you share it.
Two Democratic senators allege Tesla used 'misleading and incomplete' Full Self Driving safety statistics, citing a May 2026 Reuters investigation that found the company may have overstated its safety record by claimi...
Two Democratic senators allege Tesla used 'misleading and incomplete' Full Self Driving safety statistics, citing a May 2026 Reuters investigation that found the company may have overstated its safety record by claimi... On the same day as the regulatory pressure, Goldman Sachs analyst Mark Delaney raised Tesla's Q2 2026 delivery forecast from 405,000 to 420,000 units, above the 400,000 consensus, and maintained a Neutral rating with...
TSLA stock declined following the senators' letter, highlighting a day of conflicting signals: regulatory headwinds over FSD safety data integrity against bullish operational momentum from strong sales in the U.S., Eu...